4.6 Article

Interobserver Variation Study of the Rutgeerts Score to Assess Endoscopic Recurrence after Surgery for Crohn's Disease

期刊

JOURNAL OF CROHNS & COLITIS
卷 10, 期 9, 页码 1001-1005

出版社

OXFORD UNIV PRESS
DOI: 10.1093/ecco-jcc/jjw082

关键词

Crohn's disease; Endoscopy; postoperative endoscopic recurrence; reproducibility; Rutgeerts score

向作者/读者索取更多资源

Background: After resection surgery for Crohn's disease, recurrence of endoscopic lesions at the site of the anastomosis or in the neoterminal ileum is graded according to the Rutgeerts score (RS). The goal of this study was to test the interobserver variability for RS. Methods: Thirteen trained endoscopists evaluated the RS on 39 videotapes of patients who had undergone resection for Crohn's disease with an ileocolonic anastomosis 6 months earlier. Videotapes were randomly assigned to endoscopists through a balanced incomplete block design. Each videotape was scored independently by four endoscopists, and each endoscopist evaluated 12 videotapes, making a total of 156 videotape assessments. Reproducibility levels of the RS were assessed through unweighted kappa estimates among multiple raters. The proportion of inappropriate therapeutic initiation was estimated by randomly selecting one endoscopist for each videorecording, assuming that the majority of endoscopists correctly classified endoscopic recurrence. Results: The kappa estimates were 0.43 (95% confidence interval: 0.33-0.52) for the RS on a 5-grade scale, 0.47 (0.28-0.66) for RS < i2 vs. >= i2, and 0.64 (0.42-0.85) for RS <= i2 vs. > i2. The percentages of inappropriate therapeutic initiation were 12.8% (3.8-21.9) when initiation was triggered by a RS >= i2 and 8.3% (1.1-15.6) when initiation was triggered by a RS > i2 (p = 0.41). Conclusion: The reproducibility of the RS was moderate, especially when differentiating < i2 from >= i2, which may lead to incorrect therapeutic decisions in > 10% of patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据